Funny, there is relentless bashing on the "comments" for Karin's article, from months ago. The comments are actually funny -- claims that CDAs don't matter, they are commonplace.
Really? about 20, for a small biotech? this really is LOL
so seeing that bashing, I find it unsurprising that they would try the takedown today. Once again I will be buying.
Really? about 20, for a small biotech? this really is LOL
so seeing that bashing, I find it unsurprising that they would try the takedown today. Once again I will be buying.
2